Metronomic chemotherapy-induced bilateral subdural hematoma in a child with meningeal carcinomatosis.
Rome
Angélique
A
André
Nicolas
N
Scavarda
Didier
D
Gentet
Jean-Claude
JC
De Paula
André Maues
AM
Padovani
Laetitia
L
Pasquier
Eddy
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000068579:Celecoxib; D002648:Child; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D046648:Hematoma, Subdural, Intracranial / Q000139:chemically induced*; D006801:Humans; D008297:Male; D055756:Meningeal Carcinomatosis / Q000188:drug therapy* / Q000473:pathology; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy* / Q000473:pathology; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects
D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D005047:Etoposide; D003520:Cyclophosphamide; D000068579:Celecoxib